Skip to main content
Clinical Trials/NCT01822145
NCT01822145UnknownNot Applicable

PREDICTion of Implantable-Cardioverter Defibrillator Shock Study

Princess Margaret Hospital, Hong Kong1 site in 1 country60 target enrollmentStarted: March 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
ICD-derived T-wave alternans amplitude before ICD shock

Study Overview

Brief Summary

The primary hypothesis is that an ICD shock may be predicted days in advance by a combined score derived from different data obtainable from the ICD

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≧ 18 and ≦ 80
  • Patients have documented spontaneous and sustained ventricular arrhythmias in the last six months prior to the enrollment
  • Patients who are in sinus rhythm, have dual-chamber ICD or CRT-D implanted at least one month before enrollment
  • Patients who are in atrial fibrillation, have single-chamber ICD or CRT-D implanted at least one month before enrollment
  • Patients who are compliant to CareLink follow-up

Exclusion Criteria

  • Patients who are pregnant
  • Patients who are incapable of giving consent to the study
  • Patients who have a life-expectancy of less than 2 years

Outcomes

Primary Outcomes

ICD-derived T-wave alternans amplitude before ICD shock

Time Frame: 6 months

The T-wave alternans amplitude before an ICD shock will be measured in mV and compared to the baseline T-wave alternans amplitude

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Princess Margaret Hospital, Hong Kong
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Ngai Yin Chan

Principal investigator

Princess Margaret Hospital, Hong Kong

Study Sites (1)

Loading locations...

Similar Trials